Clinical Applications of Hepatobiliary Ultrasound: A Case-Based Approach
I. Introduction to Case-Based Learning
In the dynamic landscape of modern medicine, the transition from theoretical knowledge to practical application remains a critical challenge. Case-based learning (CBL) has emerged as a powerful pedagogical tool, bridging this gap by immersing clinicians in real-world scenarios. This approach is particularly valuable in diagnostic imaging, where pattern recognition and clinical correlation are paramount. Unlike didactic lectures that present information in isolation, CBL contextualizes findings within the complex narrative of a patient's symptoms, history, and physical examination. It forces the practitioner to think critically, weigh differential diagnoses, and understand the direct implications of imaging results on patient management. For radiologists and sonographers, this method sharpens diagnostic acumen and fosters a deeper understanding of disease pathophysiology as it manifests on the screen.
The hepatobiliary system, with its intricate anatomy and diverse pathology, is an ideal domain for case-based exploration. Ultrasound, being a first-line, non-invasive, and readily available modality, plays a central role in its evaluation. An ultrasound hepatobiliary system examination is often the initial step when a patient presents with right upper quadrant pain, jaundice, or abnormal liver function tests. Through CBL, we can appreciate not just the static images but the entire diagnostic journey—from the initial clinical suspicion to the definitive ultrasound findings and subsequent therapeutic decisions. This article adopts a case-based approach to elucidate the clinical applications of hepatobiliary ultrasound, moving through five classic presentations. It's worth noting that while this discussion focuses on abdominal ultrasound, comprehensive patient assessment sometimes requires evaluation of other systems. For instance, a patient with chronic liver disease and back pain might subsequently undergo a thoracic spine MRI to investigate possible metabolic bone disease or referred pain, highlighting the interconnected nature of diagnostic medicine. The following cases are drawn from clinical experience and are designed to reflect common and critical presentations encountered in practice, particularly relevant to populations in Hong Kong, where conditions like hepatitis B-related hepatocellular carcinoma and fatty liver disease are of significant public health concern.
II. Case 1: Acute Cholecystitis
A. Clinical presentation and ultrasound findings
A 45-year-old woman presents to the Emergency Department with sudden-onset, severe right upper quadrant (RUQ) pain that radiates to her right scapula. She reports nausea and vomiting. On examination, she is febrile (38.5°C) and has a positive Murphy's sign—inspiratory arrest upon deep palpation of the RUQ. Laboratory tests reveal leukocytosis and mildly elevated liver enzymes. The clinical suspicion is acute cholecystitis, and a point-of-care ultrasound hepatobiliary system scan is promptly performed. The sonographic findings are classic: the gallbladder is distended with a thickened, edematous wall measuring >4 mm. Within the lumen, multiple shadowing gallstones are visualized. The most specific sign, the sonographic Murphy's sign, is positive—the maximum tenderness is elicited directly under the ultrasound transducer over the gallbladder fundus. Additionally, pericholecystic fluid may be seen as a thin, anechoic rim surrounding the gallbladder. In more severe cases, complications such as gallbladder wall necrosis (appearing as irregular, discontinuous wall layers) or emphysematous cholecystitis (with gas appearing as bright, dirty shadows with reverberation artifacts) can be identified.
B. Differential diagnosis and management
While the ultrasound findings are often diagnostic, several conditions can mimic acute cholecystitis and must be considered. These include symptomatic cholelithiasis (biliary colic) without inflammation, peptic ulcer disease, acute pancreatitis, hepatitis, and even right lower lobe pneumonia. The key differentiator is the combination of gallstones, wall thickening, and a positive sonographic Murphy's sign. Management is primarily surgical, with laparoscopic cholecystectomy being the definitive treatment. Ultrasound plays a crucial role in pre-operative planning by assessing the anatomy of the cystic duct and common bile duct, and identifying any variants. In patients who are poor surgical candidates, percutaneous cholecystostomy under ultrasound guidance serves as a life-saving temporizing measure to drain the infected bile. The rapid diagnosis facilitated by ultrasound directly impacts patient outcomes, reducing the risk of progression to gangrenous cholecystitis or perforation.
III. Case 2: Liver Cirrhosis with Portal Hypertension
A. Ultrasound features of cirrhosis and portal hypertension
A 58-year-old man with a long history of chronic hepatitis B infection presents for routine surveillance. He has no specific complaints but appears mildly icteric. An ultrasound hepatobiliary system examination reveals a small, shrunken liver with a nodular, irregular surface contour. The parenchymal echotexture is coarse and heterogeneous, a hallmark of fibrosis. The caudate lobe is often disproportionately enlarged. Signs of portal hypertension are evident: the spleen is significantly enlarged (splenomegaly), measuring over 13 cm in length. Recanalization of the paraumbilical vein may be seen as a tortuous vessel running from the left portal vein to the anterior abdominal wall. Ascites, appearing as anechoic free fluid in the peritoneal cavity, particularly in the hepatorenal recess and paracolic gutters, is often present. In Hong Kong, where chronic hepatitis B remains endemic (affecting approximately 7.2% of the adult population according to recent Department of Health estimates), such ultrasound findings are unfortunately common in clinical practice.
B. Doppler assessment of portal vein flow
Doppler ultrasound is indispensable for the hemodynamic assessment of portal hypertension. The normal portal vein demonstrates a continuous, monophasic, hepatopetal (towards the liver) flow with mild respiratory variation. In portal hypertension, several abnormal patterns emerge:
- Decreased Velocity: The mean flow velocity in the main portal vein drops, often below 15 cm/sec.
- Loss of Respiratory Phasicity: The normal fluctuation with respiration is blunted.
- Hepatofugal Flow: In severe cases, the flow may reverse direction (hepatofugal), flowing away from the liver, which is a grave prognostic sign.
- Portosystemic Collaterals: Doppler can confirm flow within varices (e.g., coronary, splenorenal) and the recanalized paraumbilical vein.
IV. Case 3: Hepatocellular Carcinoma
A. Ultrasound characteristics of HCC
A 65-year-old man with known cirrhosis from hepatitis B is enrolled in a semi-annual surveillance program. His latest alpha-fetoprotein (AFP) level is elevated. A surveillance ultrasound hepatobiliary system scan identifies a new, solid liver lesion. Hepatocellular carcinoma (HCC) typically appears as a focal liver lesion with variable echogenicity. It may be hypoechoic, isoechoic, or hyperechoic. Classic features include a "mosaic" pattern (internal heterogeneity with different echogenic areas), a peripheral hypoechoic halo (representing a fibrous capsule), and posterior acoustic enhancement. Smaller HCCs are often hypoechoic, while larger ones tend to be more complex and heterogeneous due to necrosis, hemorrhage, and fatty metamorphosis. In the context of cirrhosis, any new solid nodule >1 cm is highly suspicious for HCC and warrants further characterization. The role of ultrasound extends beyond detection; it is also the primary modality for guiding percutaneous biopsy when non-invasive diagnosis is inconclusive, ensuring accurate sampling of the target lesion.
B. CEUS evaluation and biopsy guidance
When a suspicious lesion is found on grayscale ultrasound, Contrast-Enhanced Ultrasound (CEUS) is a transformative tool for characterization. Using a purely intravascular contrast agent, CEUS allows real-time observation of the lesion's vascular pattern across all phases—arterial, portal venous, and late phase. The classic enhancement pattern of HCC is "wash-in and wash-out": rapid, intense, homogeneous enhancement in the arterial phase (within 20-30 seconds post-injection) followed by washout, where the lesion becomes hypoechoic relative to the surrounding liver parenchyma in the portal venous (after 60 seconds) and late phases. This pattern has high specificity for HCC diagnosis in cirrhotic livers, often obviating the need for biopsy in treatment planning. For lesions requiring histological confirmation, ultrasound provides real-time, precise guidance for biopsy needle placement, maximizing yield and minimizing complications like bleeding or needle tract seeding. The integration of ultrasound into HCC management protocols, from surveillance to diagnosis and guidance, is a cornerstone of care, especially in high-prevalence regions like Hong Kong.
V. Case 4: Biliary Obstruction
A. Identifying the level and cause of obstruction
A 72-year-old woman presents with painless progressive jaundice, dark urine, and pale stools. An ultrasound hepatobiliary system examination is the first and most appropriate investigation. The primary goal is to answer two questions: Is the biliary system dilated? If so, what is the level and likely cause of obstruction? Ultrasound excels at demonstrating intrahepatic biliary radical dilatation, seen as "too many tubes" or a "stellate pattern" converging at the porta hepatis. The common hepatic duct (CHD) and common bile duct (CBD) are measured; a CBD diameter >7 mm (or >10 mm post-cholecystectomy) suggests obstruction. The level is determined by tracing the dilated ducts to the point of transition. A sudden cutoff at the porta hepatis suggests a hilar obstruction (Klatskin tumor). Dilation of both the intra- and extrahepatic ducts to the level of the pancreatic head points to a mid-CBD or periampullary cause. The most common causes are choledocholithiasis (an echogenic, shadowing stone within the duct) and pancreatic head carcinoma (a hypoechoic mass causing ductal compression).
B. Role of ultrasound in guiding drainage procedures
Once obstructive jaundice is confirmed, therapeutic intervention is often required. Ultrasound is invaluable in guiding these minimally invasive procedures. For percutaneous transhepatic cholangiography (PTC) and biliary drainage, ultrasound is used to select an appropriate peripheral duct for puncture, avoiding major vascular structures. Real-time guidance allows the interventional radiologist to advance the needle precisely into a dilated duct, confirming entry by aspirating bile. Subsequently, a drainage catheter can be placed to decompress the biliary system, relieving jaundice and sepsis before definitive surgery or stenting. Similarly, for endoscopic ultrasound (EUS)-guided biliary drainage, while the procedure is primarily endoscopic, ultrasound visualization from within the duodenum or stomach is critical for identifying the optimal puncture site into the dilated CBD or left hepatic duct. This image-guided approach significantly improves the safety and success rates of these complex procedures, reducing patient morbidity.
VI. Case 5: Fatty Liver Disease
A. Ultrasound grading of steatosis
A 50-year-old asymptomatic man with obesity and type 2 diabetes undergoes a routine health check. Liver enzymes are mildly elevated. An ultrasound hepatobiliary system scan is performed to evaluate for fatty liver disease, a condition of rising global and local prevalence. In Hong Kong, studies suggest the prevalence of non-alcoholic fatty liver disease (NAFLD) may be as high as 30% in the adult population, closely linked to metabolic syndrome. Ultrasound is the primary screening tool due to its accessibility and lack of radiation. Hepatic steatosis is diagnosed based on increased parenchymal echogenicity (a "bright liver") compared to the renal cortex. Ultrasound allows for semi-quantitative grading:
- Grade 1 (Mild): Slight, diffuse increase in hepatic echogenicity with normal visualization of the diaphragm and intrahepatic vessel borders.
- Grade 2 (Moderate): Moderate increase in echogenicity with slightly impaired visualization of the diaphragm and intrahepatic vessels.
- Grade 3 (Severe): Marked increase in echogenicity with poor penetration, significant posterior attenuation (shadowing), and poor or non-visualization of the diaphragm and intrahepatic vessel borders.
B. Monitoring disease progression and response to treatment
Ultrasound serves as a practical tool for monitoring the course of fatty liver disease. In patients who implement lifestyle modifications—such as weight loss, dietary changes, and increased exercise—serial ultrasound examinations can demonstrate a reduction in liver echogenicity, indicating improvement in steatosis. Conversely, progression of disease, potentially to steatohepatitis (NASH) and cirrhosis, can be suspected if the liver becomes smaller, more nodular, or if signs of portal hypertension develop. While ultrasound is excellent for detecting moderate-to-severe steatosis, it is less sensitive for mild steatosis and cannot reliably differentiate simple steatosis from NASH. In complex cases where advanced fibrosis is suspected, or if a focal lesion is found in a fatty liver (which can be challenging due to the background echogenicity), further imaging with modalities like MRI elastography or a dedicated liver MRI may be indicated. It is important to maintain a holistic view; for example, a patient with metabolic syndrome and back pain might have unrelated degenerative spine disease, for which a thoracic spine MRI could be indicated, but this should not distract from the primary management of their liver condition.
VII. Integrating Ultrasound into Clinical Practice
The journey through these five cases underscores the indispensable role of hepatobiliary ultrasound as a versatile, dynamic, and patient-centered diagnostic tool. From the emergency diagnosis of acute cholecystitis to the nuanced surveillance of cirrhosis and HCC, ultrasound provides immediate, actionable information that directly shapes clinical pathways. Its strengths lie in its real-time capability, lack of ionizing radiation, excellent spatial resolution for superficial structures, and its utility in guiding interventions. The case-based approach reinforces that ultrasound findings are never interpreted in a vacuum; they are integral pieces of a clinical puzzle that includes history, examination, and laboratory data. For the practicing clinician, developing proficiency in interpreting ultrasound hepatobiliary system examinations—or knowing when to refer for one—is essential for efficient and effective patient care. As technology advances with techniques like elastography and 3D/4D imaging, the applications will only expand. Ultimately, the goal is to seamlessly integrate this powerful modality into a cohesive diagnostic strategy, ensuring that each patient receives timely, accurate, and personalized management, from the initial point of care through to treatment and follow-up.
Related Articles
10 Questions to Ask Your Oncologist About Immunotherapy
